Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.

The market for hemostatic agents has witnessed significant growth recently, driven by evolving medical needs and advancements in surgical techniques. With increasing surgical procedures and rising demand for innovative products, this sector is positioned for continued expansion. Below, we explore the current market size, key growth drivers, segmentation, strategic developments, and regional outlook for hemostatic agents.

Hemostatic Agents Market Size Projections and Growth Potential

The hemostatic agents market has experienced robust growth over recent years. It is projected to rise from $4.42 billion in 2025 to $4.66 billion in 2026, growing at a compound annual growth rate (CAGR) of 5.4%. This historical growth is largely due to the limited variety of hemostatic agents available, dependence on traditional thrombin and gelatin products, an increasing volume of surgical procedures, expansion in hospital infrastructure, and heightened awareness regarding the management of blood loss.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25780&type=smp

Looking ahead, the market is forecasted to continue its upward trajectory, reaching $5.71 billion by 2030 with a CAGR of 5.2%. The anticipated growth is driven by innovations such as recombinant and sprayable fibrin sealants, a surge in minimally invasive and orthopedic surgeries, greater demand for combination and multi-agent hemostats, and increased use in plastic and neurosurgical procedures. The market will also be influenced by stricter regulatory requirements focused on sterility and biocompatibility. Key trends expected to shape the market include rising adoption of advanced hemostatic agents during surgeries, growth in fibrin sealants and biologically sourced products, expanded use in trauma and cardiovascular surgeries, and a stronger emphasis on safety and regulatory compliance.

Growing Number of Surgeries Boosting Hemostatic Agents Demand

One of the primary factors propelling the hemostatic agents market is the rising volume of surgical procedures worldwide. Surgical operations, which involve specialized techniques to treat, repair, or remove bodily tissues, are increasingly performed to address a growing number of chronic health conditions. These procedures often require effective blood loss control, and hemostatic agents play a crucial role in quickly stopping bleeding, reducing blood loss, and improving surgical visibility for precise interventions.

Access The Complete Hemostatic Agents Market Report:

https://www.thebusinessresearchcompany.com/report/hemostatic-agents-global-market-report

Supporting this trend, data from the UK Health Security Agency (UKHSA) revealed that during the 2023–24 period, there were 135,619 recorded operations with 1,276 surgical site infections identified, marking an 8.4% increase in reported procedures compared to the prior year. This rise in surgeries directly contributes to greater demand for hemostatic agents.

Detailed Segmentation of the Hemostatic Agents Market

The market for hemostatic agents is categorized based on type, application, and end-user:

By Type:

– Thrombin-Based Hemostats

– Gelatin-Based Hemostats

– Collagen-Based Hemostats

– Oxidized Regenerated Cellulose-Based Hemostats

– Combination Hemostats

– Fibrin Sealants

– Other Types

By Application:

– Trauma

– Cardiovascular Surgery

– General Surgery

– Plastic Surgery

– Orthopedic Surgery

– Neurosurgery

– Other Applications

By End-User:

– Hospitals

– Surgery Centers

– Nursing Homes

– Other End Users

Further subcategories include thrombin-based products like bovine and human thrombin, gelatin-based forms such as absorbable sponges and powders, collagen sponges and sheets, oxidized cellulose pads and meshes, combination agents merging various bases, fibrin sealants including recombinant and sprayable types, and other varieties such as polysaccharide- and synthetic polymer-based hemostats.

Advances in Hemostatic Technology Guiding Market Evolution

Key players in the hemostatic agents industry are concentrating on innovating more efficient products, especially collagen-based hemostats that enable rapid hemostasis and tissue sealing in both open and minimally invasive surgeries. These collagen-based materials work by supporting the body’s natural clotting response at wound sites.

For example, in March 2025, Baxter introduced HEMOPATCH Sealing Hemostat, a collagen-based absorbable pad featuring a dual-action system combining a collagen matrix with an NHS-PEG layer that forms a hydrogel upon contact with moisture. This design allows for fast sealing of bleeding areas, strong adhesion to wet tissues, and suitability for diverse surgical approaches. The patch achieves hemostasis in under two minutes without requiring cold storage or special preparation, simplifying surgical workflows. It also biodegrades naturally within 6 to 8 weeks and can be stored at room temperature for up to three years, fulfilling key clinical and logistical needs.

Prominent Companies Shaping the Hemostatic Agents Industry

The competitive landscape of the hemostatic agents market includes several leading corporations such as Pfizer Inc., Johnson & Johnson Services Inc., Becton Dickinson & Co., CSL Ltd., Baxter International Inc., Teleflex Inc., Integra LifeSciences Holdings Corp., Gelita Medical, Artivion Inc., B. Braun Melsungen AG, Advanced Medical Solutions Group Plc, Z‑Medica, Marine Polymer Technologies Inc., MedTrade Products Ltd., Samyang Holdings Corp., Vascular Solutions Pc, BioCer Entwicklungs GmbH, Starch Medical Inc., Arch Therapeutics Inc., Medcura Inc., and Biom’Up SAS.

Regional Perspective and Market Share Insights

In 2025, North America held the largest share of the hemostatic agents market. The market report further analyzes regions including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East, and Africa, providing a comprehensive view of geographic trends and growth opportunities worldwide.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model